Physician profile
Eric M North
NPI 1205807112
$7,601.05
in general payments reported to CMS, 2019-2025
43 companies · $1,314 in 2025
The $1,314 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,096 · 2020: $802 · 2021: $810 · 2022: $1,232 · 2023: $1,244 · 2024: $1,104 · 2025: $1,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,623 · Education: $38.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,622.97 |
| Education | $38.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $796.23 | 2019-2025 | |
| Pfizer INC. | $791.42 | 2019-2025 | |
| Novo Nordisk INC | $745.85 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $671.86 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $556.77 | 2019-2025 | Evenity, Prolia, Prolia |
| Glaxosmithkline, LLC. | $470.79 | 2019-2025 | Shingrix, Bexsero, Arexvy |
| Lilly USA, LLC | $466.06 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $382.07 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $317.72 | 2022-2025 | Rexulti, Abilify Maintena |
| Abbott Laboratories | $243.82 | 2021-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $169.73 | 2019-2022 | |
| Exact Sciences Corporation | $164.77 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $164.06 | 2019-2024 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.44 | 2020-2024 | Jardiance |
| Biohaven Pharmaceutical Holding Company Ltd. | $149.95 | 2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric North listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.